Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 4 | History Defined

Supreme Court Halts Purdue Pharma’s $6B Settlement From A Challenge In A Lawsuit

The Supreme Court temporarily blocked a bankruptcy settlement by Purdue Pharma that would shield victims from civil lawsuits.

Zenger

Supreme Court blocks Purdue Pharma bankruptcy deal that shields Sackler family from lawsuits

Justices will hear arguments in the case in December

The Independent UK

Supreme Court temporarily blocks $6 billion Purdue Pharma-Sackler bankruptcy

Supreme Court's decision to review the controversial bankruptcy deal involving the maker of Oxycontin means the settlement will remain on hold at least through December.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Fast-paced ‘Painkiller’ depicts the making, selling and often devastating effects of OxyContin

Netflix limited series recounts Purdue Pharma’s work on the addictive drug from the perspective of its leader, some sellers, an investigator and a victim.

Chicago Sun-Times

Painkiller on Netflix review: this drama exploring America’s opioid crisis feels achingly real

This show skilfully captures the impossible emotional complexity of loving an addict

Evening Standard

Painkiller review: The harrowing story of the opioid crisis has been told much more movingly elsewhere

Matthew Broderick stars as Purdue Pharma head Richard Sackler in this thinly written Netflix drama about the rise of Oxy – ‘Dopesick’ did it better

The Independent UK

Painkiller: release date, cast, plot and everything we know

Painkiller is a scripted limited series that explores the opioid crisis in America. Here's what we know about the Netflix series.

WhatToWatch

Read news from The Economist, FT, and more,
with one subscription

Court says OxyContin maker's bankruptcy and protections for Sackler family members can move ahead

OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family who own the company to avoid civil lawsuits over the opioid crisis, a court has ruled

The Independent UK

Revolving Door: DEA’s No.2 quits amid reports of previous consulting work for Big Pharma

The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma

The Independent UK

LOCALIZE IT: State and local governments figuring out how to use opioid settlement money

EDITORS/NEWS DIRECTORS:

The Independent UK

A landmark appeals court ruling clears way for Purdue Pharma-Sackler bankruptcy deal

The 2nd Circuit Court of Appeals in New York cleared the way for a controversial bankruptcy deal that grants immunity from opioid lawsuits to members of the Sackler family.

WEKU

Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits

A federal court ruling has cleared the way for OxyContin maker Purdue Pharma to settle thousands of legal claims over the toll of opioids

The Independent UK

King’s College London cuts ties with opioids-linked Sackler family

University is latest body to distance itself from sponsorship by owners of Purdue Pharma, makers of OxyContin

The Guardian - UK

Governments are increasingly reliant on consulting firms. Critics says it's often to their detriment

Critics say governments are outsourcing their own knowledge and activities to consulting firms, yet these firms aren't held to the same standards as the public sector.

ABC News

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

I’ve seen how overdose wrecks lives – why have the Sackler family members behind OxyContin avoided all charges?

I filmed as activists held Purdue Pharma’s owners to account. Yet the US government has utterly failed to play its part, says film-maker Laura Poitras

The Independent UK

Nan Goldin is going to the Oscars, and she wants to win

It’s not always emphasized given that she’s one of the most groundbreaking still photographers of the past 50 years

WEKU

'All the Beauty and the Bloodshed' chronicles Nan Goldin's career of art and activism

Filmmaker Laura Poitras and Goldin discuss their Oscar-nominated documentary about efforts to remove the Sackler family name from prominent museums amid the opioid epidemic.

Evening Standard

All the Beauty and the Bloodshed review: Nan Goldin documentary will leave you emotionally wrecked

The film weaves the artist’s fight with the Sackler family over the opioid crisis with her own tragic backstory

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

US health agency accused of bowing to drug industry with new opioid guidance

Doctors say CDC’s softer guidelines ‘tossing aside’ safety limits put lives at risk as opioid epidemic continues to rage in the country

WEKU

How one artist took on the Sacklers and shook their reputation in the art world

A new documentary All The Beauty and the Bloodshed tells the story of Nan Goldin, a photographer and activist who survived opioid addiction — then challenged members of the Sackler family.

The Guardian - UK

Artist Nan Goldin on addiction and taking on the Sackler dynasty: ‘I wanted to tell my truth’

Her battle against the billionaires who fuelled the opioid epidemic upended the art establishment. As a film about her life is released, she talks about family tragedy and her journey to activism

The Guardian - US

When McKinsey Comes to Town review: the book to consult on opioids, China and more

Walt Bogdanich and Michael Forsythe of the New York Times have done their homework on the management giant

The Philadelphia Inquirer

Ex-owner of Philly pharmacy that pushed more OxyContin than any other US drug store is sentenced to prison

PHILADELPHIA — The longtime owner of a Northeast Philadelphia pharmacy that once prescribed more OxyContin than any drug store in the country has been sentenced to prison and ordered to pay more than $4 million to settle claims of defrauding the government.

WEKU

How McKinsey cashed in by consulting for both companies and their regulators

When McKinsey Comes to Town authors Walt Bogdanich and Michael Forsythe say the consulting firm helped companies boost tobacco and opioid sales — while at the same time working for the FDA.

The Guardian - UK

V&A drops financial ties with Sackler family over links with opioids

London museum bows to years of pressure and removes signs bearing name of family associated with OxyContin crisis

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.